Infection Protection
Show
- Nanotechnology
- Nanosilver No ‘Silver Bullet’
- A popular treatment for microbial infections may lose its effectiveness when used in long-term
- 528 0
- Urinary System
- What You Need to Know About Urinary Tract Infections
- New study finds women who experience recurrent UTIs are unhappy with limited management options for the painful condition
- 1935 0
- Genetic Research
- For some peptides, killing bacteria is an inside job
- Rice chemists’ analysis advances research on alternatives to antibiotics
- 3197 0
- Infectious Disease
- FDA authorizes bamlanivimab and etesevimab monoclonal antibody therapy for post-exposure prophylaxis (prevention) for COVID-19
- The FDA has revised the EUA to authorize bamlanivimab and etesevimab monoclonal antibody therapy for certain individuals in/with specific conditions
- 2347 0
-
- Nanotechnology
- Nanosilver No ‘Silver Bullet’
- A popular treatment for microbial infections may lose its effectiveness when used in long-term
- 528 0
-
- Urinary System
- What You Need to Know About Urinary Tract Infections
- New study finds women who experience recurrent UTIs are unhappy with limited management options for the painful condition
- 1935 0
-
- Genetic Research
- For some peptides, killing bacteria is an inside job
- Rice chemists’ analysis advances research on alternatives to antibiotics
- 3197 0
-
- Infectious Disease
- FDA authorizes bamlanivimab and etesevimab monoclonal antibody therapy for post-exposure prophylaxis (prevention) for COVID-19
- The FDA has revised the EUA to authorize bamlanivimab and etesevimab monoclonal antibody therapy for certain individuals in/with specific conditions
- 2347 0
Load More
